THE LATEST Trump says tariffs on Canada, Mexico will go forward on Tuesday Frankfurt - Delayed Quote • EUR Vaxcyte, Inc. (5VA.F) Follow Compare 69.50 -1.00 (-1.42%) At close: March 3 at 8:08:39 AM GMT+1 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 5VA.F 1D 5D -7.33% 1M -17.75% 3M -19.19% 6M -4.14% YTD -13.66% 1Y 2.96% 5Y 58.30% All 58.30% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: 5VA.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Vaxcyte, Inc. (PCVX): Among the Cash-Rich Mid Cap Stocks to Buy Now Why Vaxcyte, Inc. (PCVX) Is One of the Best Vaccine Stocks to Buy According to Hedge Funds Q4 2024 Vaxcyte Inc Earnings Call Vaxcyte Inc (PCVX) Q4 2024 Earnings Call Highlights: Strong Financial Health and Promising ... Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update Vaxcyte, Inc. (PCVX): Among the Stocks That Will Go to The Moon According to Analysts It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 Why Vaxcyte, Inc. (PCVX) Is Among the Best Healthcare Stocks To Buy According to Analysts Vaxcyte advances second stage of Phase 2 study evaluating VAX-31 Vaxcyte enters final stage of Phase II pneumococcal vaccine trial in infants Related Tickers RGO.SG Regeneron Pharmaceuticals Inc 653.00 -2.77% ACLX Arcellx, Inc. 62.63 -3.38% CAPR Capricor Therapeutics, Inc. 13.67 -11.12% MRNA Moderna, Inc. 30.27 -2.23%